|
News For PFE;GSK From The Last 14 Days Check below for free stories on PFE;GSK the last two weeks. |
|
|
| June 19, 2013 |
| 17:52 EDT |  | PFE | Pfizer announces final exchange ratio for Zoetis exchange offer
 Subscribe for More Information |
|
| 16:01 EDT |  | PFE | Options Update; June 19, 2013
Subscribe for More Information |
|
| 10:30 EDT |  | PFE | Pfizer management to meet with ISI Group
Subscribe for More Information |
|
| 07:41 EDT |  | PFE | Pfizer holders should consider Zoetis exchange, says BMO Capital
BMO Capital thinks Pfizer (PFE) investors should consider participating in the Zoetis (ZTS) exchange as they have the opportunity to own Zoetis at around $29.40-$29.70 per share, which is 15% below BMO's valuation of $34 per share. Further, BMO thinks there is strong support for Zoetis below $30, which the firm feels lowers downside risk. BMO recommends that Pfizer investors tender around 20% of their shares into the exchange, noting that with the offer likely being oversubscribed, not all tendered shares will be converted to Zoetis. |
|
| June 18, 2013 |
| 09:38 EDT | | PFE | Active equity option families trading on open
Active equity option families trading on open according to Track Data: AAPL NFLX GOOG PFE TSLA MGM |
|
| 08:37 EDT |  | GSK | Drug companies turn to microchips to test medicines, WSJ reports
Subscribe for More Information |
|
| 07:13 EDT | | GSK | Aspen in talks buy GSK's Arixtra, Fraxiparine brands
Subscribe for More Information |
|
| 07:07 EDT | | GSK | GlaxoSmithKline receives offer for thrombosis brands from Aspen
GlaxoSmithKline said it received an offer for its thrombosis brands and Notre-Dame de Bondeville site from Aspen Global. A period of exclusivity has been agreed with Aspen. The financial terms are confidential at this time, but the offer includes the transfer of the Arixtra and Fraxiparine brands to Aspen, along with the related manufacturing site and the majority of employees at NDB in France and certain dedicated commercial employees, GSK said. "The proposed transaction is aligned to GSK's strategy of focusing on products with the most growth potential and the delivery of its pipeline," the company added. |
|
| June 17, 2013 |
| 16:00 EDT | | PFE | Options Update; June 17, 2013
Subscribe for More Information |
|
| 08:36 EDT | | PFE | InSite Vision to join Merck, Pfizer patent suit against Mylan
InSite Vision (INSV) announced that it will join Merck (MRK) and Pfizer (PFE) in filing a patent infringement lawsuit against Mylan Pharmaceuticals (MYL). Mylan recently filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking to market a generic version of AzaSite before expiration of the patents covering AzaSite and its use. AzaSite is marketed by Merck in the U.S. On May 26, 2011, InSite and Merck filed a similar patent infringement lawsuit against Sandoz. A trial date for the Sandoz ANDA suit has been set for July 11, 2013. The companies have agreed that Merck will take the lead in prosecuting both lawsuits. Each company will be responsible for their own legal costs, with InSite assuming a monitoring role, the company said. |
| |
| 07:28 EDT | | PFE | Cambridge Healthtech Institute to host a conference
Subscribe for More Information |
|
| June 14, 2013 |
| 16:00 EDT | | PFE | Options Update; June 14, 2013
Subscribe for More Information |
|
| 06:45 EDT | | PFE | Zoetis volatility elevated into Pfizer split-off
Subscribe for More Information |
|
| June 13, 2013 |
| 16:00 EDT | | PFE | Options Update; June 13, 2013
Subscribe for More Information |
|
| 07:32 EDT | | PFE | European League Against Rheumatism to host annual meeting
Subscribe for More Information |
|
| June 12, 2013 |
| 19:54 EDT | | GSK | GlaxoSmithKline investigates bribe claims in China, WSJ says
Subscribe for More Information |
|
| 16:02 EDT | | PFE | Options Update; June 12, 2013
Subscribe for More Information |
|
| 13:31 EDT | | PFE | Mylan could be interested in generic assets split from Pfizer, Bloomberg says
|
|
| 08:28 EDT | | PFE | Teva to pay $1.6B to settle with Pfizer, Nycomed over generic Protonix
Subscribe for More Information |
|
| 08:02 EDT | | PFE | Pfizer wins $2.15B settlement from Teva and Sun for patent infringement
Subscribe for More Information |
| |
|
|
|
|
